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Abstract Protein kinase C-a is a member of the n-protein
kinase C subfamily that in mitotic cells translocates to
centrosomes and kinetochores. Although this kinase is expressed
in comparable amounts in murine erythroleukaemia cells during
the interphase or metaphase, when localized in the mitotic
structures, it selectively phosphorylates a 66 kDa protein, also
associated to chromosomes. Moreover, protein kinase C-a
immunoprecipitated from cells at the metaphase results four
times more active in the absence of lipid cofactors as compared
with the kinase obtained from cells in the interphase. This
activation is accomplished by interaction of protein kinase C-a
with a protein factor which also promotes an increased auto-
phosphorylation of the kinase. These findings indicate that in the
mitotic phase of the cell cycle, protein kinase C-a recognizes a
protein factor which operates as a positive modulator of the
kinase activity in the absence lipids.
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1. Introduction
Individual protein kinase C (PKC) isoenzymes are involved
in speci¢c signal transduction pathways [1^4] as well as in the
regulation of multiple basal cell functions, including the con-
trol of intracellular pH, maintenance of the cytoskeleton and
progression of the cell cycle [5^8]. The di¡erent functions
attributed to single members of the PKC family expressed in
eukaryotic cells cannot be explained only on the basis of dif-
ferences observed in their catalytic properties, such as sub-
strate speci¢city or sensitivity to activators [9^12]. It has
been hypothesized that the subcellular localization, the pres-
ence of characteristic domains, capable to promote or prevent
association of PKCs with speci¢c sites and interaction with
activating or inhibiting protein factors could play a relevant
role for the intracellular modulation of PKC isoenzyme activ-
ities. In fact, it has been recently reported that isoenzymes
belonging to the conventional, novel or atypical PKC subfa-
milies [13] interact with speci¢c proteins both under in vivo
and in vitro conditions [9,14,15]. Several RACK proteins have
been yet identi¢ed as sites of binding for activated PKC iso-
enzymes [16]. Moreover, it has been proposed that protein
receptors speci¢c for the inactive form of the kinases (RICKs)
are capable to anchor single PKC isoenzymes to di¡erent
subcellular sites. A number of molecular motifs, identi¢ed
both in the regulatory and catalytic domain of PKC isoen-
zymes, seem to be involved in these associations [17].
We reported previously that PKC plays a fundamental role
in murine erythroleukaemia (MEL) cell di¡erentiation [18].
However, the level of PKC-K, that in these cells is present
in two forms, is positively correlated with the sensitivity to
the chemical inducer and the decrease in the latent period
preceding cell commitment [19]. An opposite role is played
by PKC-N, an isoenzyme highly expressed in inducer-resistant
MEL cell clones and rapidly down-regulated following induc-
tion [20]. More recently, we observed that PKC-a, an almost
completely nuclear PKC isoenzyme in MEL cells, seems not
to be involved in MEL cell commitment and disappears late
during the multistep di¡erentiation process, at a time corre-
sponding to the cell acquirement of the ungrowing phenotype
[21]. PKC-a, a member of the novel PKC subfamily, has been
indicated as a mediator of many speci¢c functions in di¡erent
cell types. This PKC isoenzyme is required in the process of
apoptosis in thymocytes [22], during mitosis and formation of
F-actin stress ¢bers in endothelial cells [6] and in the process
of activation of T-cells [23]. Moreover, the 14-3-3 tau protein
has been proposed as a speci¢c modulator of PKC-a functions
preventing its translocation to the plasma membrane in Jurkat
T-cells [24]. A speci¢c PKC-a protein substrate, moesin, has
also been identi¢ed in human leucocytes, among the mem-
brane/cytoskeletal linkage proteins [25]. In MEL cells, as
well as in other murine and human cells, PKC-a associates
to centrosomes and kinetochores during mitosis [21], suggest-
ing an active role for this kinase in the control of protein
functions linked to the cell cycle progression. To establish
the biochemical relevance of the interaction of PKC-a to mi-
totic spindle and chromosomal structures, here, we have in-
vestigated the expression of phosphorylating activity of the
kinase recovered from mitotic MEL cells, searching also for
protein substrates localized in the same structures.
2. Materials and methods
2.1. Cell culture, synchronization and induction of di¡erentiation
N23 MEL cells were obtained and cultured as speci¢ed previously
[26]. Cells were arrested at the metaphase by thymidine/nocodazole
(Sigma Chemical) treatment as described [27] except that the concen-
tration of nocodazole was lowered to 50 ng/ml. This procedure re-
sulted in a mitotic index of 80% as judged by £uorescence labelling of
DNA [28]. MEL cell di¡erentiation was induced by addition of 5 mM
hexamethylenebisacetamide (HMBA) (Sigma Chemical) to a culture
containing 105 cells/ml. At the indicated times, the percentage of dif-
ferentiated cells was determined by the benzidine reaction method
[29].
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2.2. Immunoprecipitation of PKC-a and assay of catalytic activity
N23 MEL cells (107 cells) were immunoprecipitated with an a⁄n-
ity-puri¢ed polyclonal antibody raised against the C-terminal peptide
of mouse PKC-a (Santa Cruz Biotechnology) [21]. To assay for PKC
activity, the immunoprecipitates were washed ¢ve times with 1 ml of
20 mM Tris-HCl, pH 7.6, containing 0.14 M NaCl, 2.5 mM EDTA
and 2.5 mM EGTA. The pellet was suspended in 50 Wl washing bu¡er
and aliquots were diluted in 100 Wl of a mixture containing 5 mM
dithiothreitol, 15 mM MgCl2, 10 WM ATP, 10 WCi [Q32P]ATP, 1 WM
okadaic acid in the absence or presence of a chromosome preparation
obtained from 106 MEL cells as speci¢ed in Section 2.4. The presence
of other additions in the assay mixture is speci¢ed elsewhere. After 30
min at 37‡C, the reaction was stopped with electrophoresis sample
bu¡er, followed by SDS-PAGE on a 8% polyacrylamide gel and auto-
radiography. The amount of radioactivity incorporated in a protein
band was determined by the area of the densitometric peak [21].
2.3. Quantitative analysis of PKC-a by Western blot
MEL cells were lysed in the sample bu¡er for electrophoresis and
submitted to SDS-PAGE on a 8% polyacrylamide gel. Western blot-
ting and the quantitative evaluation of PKC-a present on each electro-
phoretic lane were carried out as speci¢ed previously [21].
2.4. Isolation of chromosomes from MEL cells
To obtain puri¢ed chromosomes, N23 MEL cells (2U107 cells)
were synchronized at the metaphase as reported above, then collected
by centrifugation and rinsed twice with PBS. Chromosomes were then
puri¢ed as described [30] and stored at 370‡C.
2.5. Characterization of the PKC-a activating factor
To establish the molecular identity of the activating factor co-im-
munoprecipitated with PKC-a, 3U107 MEL cells were synchronized
at the metaphase and PKC-a was immunoprecipitated as speci¢ed
above. Immunoprecipitates were then divided into identical aliquots.
The ¢rst one was incubated with trypsin (ratio 200:1, w:w) for 2 h at
37‡C and the reaction was stopped by heating the mixture at 75‡C for
3 min. A second aliquot was extracted with one volume of ether for
10 min at 20‡C, then, the aqueous and ether phases were dried by
lyophilization, diluted in the original volume and heated for 3 min at
75‡C. A third aliquot was maintained for 2 h at 37‡C followed by
heating as above.
3. Results
In order to evaluate changes in the amount of PKC-a ex-
pressed by MEL cells at di¡erent stages of the cell cycle, we
measured the level of the kinase in cells collected from cul-
tures containing 90% of cells in the interphase or 80% cells
synchronized at the metaphase. As shown in Fig. 1A, Western
blot analysis reveals that the amount of the 76 kDa PKC-a
immunoreactive band is very similar in both conditions and
no degradation fragments, which produce 40^50 kDa immu-
noreactive bands containing the catalytic domain of this kin-
ase [31], are detectable. These data indicate that subcellular
redistribution of PKC-a occurring during the MEL cell cycle
is not accompanied by a proteolytic processing or a down-
regulation of the kinase.
Due to the fact that at present, a rapid puri¢cation proce-
dure is not available to obtain a high yield of native PKC-a,
we selected the single step immunoprecipitation method to
separate PKC-a from the other PKC isoenzymes present in
MEL cells. PKC-a immunoprecipitates, obtained using an
anti-peptide antibody raised against the caboxy-terminal pep-
tide of the kinase, were analyzed by a Western blot and re-
sulted free of any other PKC isoenzyme previously reported
to be expressed by MEL cells (data not shown) [21]. Further-
more, since the protein or peptide substrates of PKC-a are
poorly characterized, we used a chromosomal preparation to
evaluate the presence of an intracellular substrate for PKC-a
localized in a cell structure on which the kinase is recruited
during mitosis. As shown in Fig. 2, addition of PKC-a im-
munoprecipitated from MEL cells to a chromosome prepara-
Fig. 1. The level of PKC-a in MEL cells during the interphase or
metaphase. MEL cells (105 cells) in the interphase (Ip) or from a
culture synchronized at the metaphase (Mp) were submitted to
SDS-PAGE followed by a Western blot for PKC-a as described in
Section 2. The hatched bars represent a quanti¢cation of PKC-a by
densitometric analysis of the 76 kDa band detected by the chemilu-
minescence method, as speci¢ed in Section 2. The data are reported
as mean þ S.D. for triplicate measurements. Arrows on the right of
the Western blot indicate the migration of molecular weight
markers.
Fig. 2. Identi¢cation of PKC-a substrates on isolated chromosomes.
Chromosomes puri¢ed from 106 MEL cells at the metaphase were
phosphorylated, as speci¢ed in Section 2, in the absence or presence
of PKC-a immunoprecipitated from 3U105 unsynchronized cells.
After 30 min at 37‡C, the reactions were stopped by addition of
electrophoresis bu¡er and submitted to SDS-PAGE followed by
autoradiography.
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tion in the presence of [Q32P]ATP results in the incorporation
of 32P in a protein band having a molecular mass of approx-
imately 66 kDa. It has been reported that phorbol-12-myris-
tate-13-acetate (PMA) and phosphatidylserine (PS) stimulate
PKC-a activity [6]. Addition of these lipid cofactors to the
assay mixture enhances the incorporation of 32P into the 66
kDa chromosomal protein 4-fold (cf. lanes 5 and 6). Chromo-
somes or PKC-a alone do not show any appreciable phos-
phorylated band in these conditions.
These data indicate that the 66 kDa chromosomal protein is
a true PKC-a substrate, requiring lipid cofactors for maximal
phosphorylation and that it can be used to assay PKC-a ac-
tivity alternatively to the commercial peptide substrates.
We evaluated the possibility that PKC-a undergoes changes
of catalytic properties following its translocation on the spin-
dle pole during mitosis. The kinase was isolated by immuno-
precipitation from MEL cells in the interphase or synchron-
ized at the metaphase and the two PKC-a preparations were
then incubated with chromosomes in the absence or presence
of lipid cofactors. As shown in Table 1, both PKC-a samples
exhibit a similar phosphorylating activity when assayed in the
presence of PMA and PS. On the contrary, the enzyme iso-
lated from cells in the interphase expresses 15% of its maximal
activity in the absence of lipids, whereas the enzyme obtained
from metaphasic cells expresses more than 60% of its maximal
catalytic activity. This di¡erence indicates that the kinase is
more active during the metaphase, i.e. in the form associated
with centrosomes and kinetochores.
To establish whether the PKC-a activating agent, present in
immunoprecipitates from metaphasic cells, was due to the
presence of a protein or a lipid molecule, the immunoprecipi-
tates were at ¢rst heated for 3 min at 75‡C to obtain a com-
plete inactivation of PKC-a (data not shown) followed by
incubation with trypsin or, alternatively, extraction with ether.
Each immunoprecipitate was ¢nally assayed for the presence
of the PKC-a activating factor by addition of chromosomes,
as source of a protein substrate, and PKC-a obtained from
interphasic or metaphasic cells. As shown in Table 2, PKC-a
from metaphasic cells phosphorylates the 66 kDa chromoso-
mal substrate with a comparable high e⁄ciency both in the
absence or in the presence of the heated immunoprecipitate.
On the contrary, PKC-a from cells in the interphase shows a
5-fold increase in the 66 kDa chromosomal protein phospho-
rylation when the heated immunoprecipitate is added to the
assay mixture. Treatment of the heated immunoprecipitate
with trypsin results in the disappearance of the PKC-a acti-
vating e¡ect, whereas, following extraction with ether, the
activating factor is recovered in the aqueous phase. These
data indicate that, in mitotic MEL cells, PKC-a associates
and co-immunoprecipitates together with a protein factor act-
ing as a stimulating cofactor for the kinase activity. PKC-a
immunoprecipitates from cells in the interphase, on the con-
trary, do not contain any detectable PKC-a activating factor
(data not shown).
We also explored the possibility that this PKC-a activating
protein could operate on the auto-phosphorylation process of
the kinase, a speci¢c event accompanying PKC activation [32].
The heated PKC-a immunoprecipitate from metaphasic cells
was then added to PKC-a isolated both from interphasic or
metaphasic cells in the absence or presence of the classical
lipid cofactors PMA and PS. As shown in Fig. 3, in the
absence of lipids, the incorporation of 32P into PKC-a isolated
from interphasic cells (76 kDa phosphorylated band, lane 1) is
very poor. However, addition of PKC-a-heated immunopre-
cipitate increases the extent of auto-phosphorylation of the
kinase 5-fold. A similar enhancement of the auto-phosphor-
ylating activity is obtained by addition of the lipid cofactors
to the assay mixture. Conversely, auto-phosphorylation of
PKC-a obtained from metaphasic cells occurs at a high extent
in the absence of any addition and is not further stimulated by
lipid cofactors. The identity between the phosphorylated pro-
tein band showing a molecular mass of 76 kDa and the PKC-
a molecule was also con¢rmed by overlapping of the 32P band
and PKC-a immunoreactive band detectable by a Western
blot on the same electrophoretic run (data not shown).
4. Discussion
We recently established that, although many PKC isoen-
zymes are located in the nucleus of MEL cells, PKC-a is the
only isoform completely recovered on mitotic spindle struc-
tures [21]. A speci¢c association of PKC-a to recognition sites
on centrosomes and kinetochores occurs in mitotic cells both
of human and murine origin, suggesting that this PKC-a tar-
getting process is probably involved in cell cycle progression.
This conclusion is also supported by results demonstrating
that PKC-a is absent from the nucleus of ungrowing cells
Table 1
Requirement of lipid cofactors by PKC-a isolated from MEL cells
in the interphase or metaphase
Cell condition Addition PKC-a activity (cpm/sample)
Interphase None 150 þ 30
PMA+PS 980 þ 80
Metaphase None 650 þ 70
PMA+PS 1 000 þ 100
Each PKC-a assay mixture (100 Wl) contained the additions speci¢ed
in Section 2, PKC-a immunoprecipitated from the indicated cell
source, a chromosome preparation from 107 MEL cells and, where
indicated, 160 nM PMA and 100 Wg/ml PS. After 30 min at 37‡C,
the samples were stopped and submitted to SDS-PAGE as reported
in Section 2. The 32P band corresponding to the 66 kDa chromoso-
mal protein was excised and counted in a scintillation counter. Data
represent mean þ S.D. of three replicate determinations.
Table 2
Properties of a PKC-a activating factor
Cell condition Addition PKC-a activity
(cpm/sample)
Interphase None 240 þ 40
h.i.p. 1 250 þ 90
Trypsin-treated h.i.p. 300 þ 30
Ether-extracted h.i.p.
Aqueous phase 1 110 þ 130
Organic phase 260 þ 50
Metaphase None 1 420 þ 120
h.i.p. 1 560 þ 100
Each PKC-a assay mixture (100 Wl) contained the additions speci¢ed
in Section 2, PKC-a immunoprecipitated from the indicated cell
source, a chromosome preparation from 107 MEL cells and, where
indicated, a sample of heated PKC-a immunoprecipitate (h.i.p.) un-
treated or previously treated with trypsin or extracted with ether
(see Section 2). After 30 min at 37‡C, the samples were stopped and
submitted to SDS-PAGE as reported in Section 2. The 32P band
corresponding to the 66 kDa chromosomal protein was excised and
counted in a scintillation counter. Data represent mean þ S.D. of
three replicate determinations.
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and is also almost completely down-regulated in terminal dif-
ferentiated erythroid cells [21]. We now provide experimental
evidence indicating that in mitotic MEL cells, PKC-a is
present in an active form. In fact, a chromosomal protein
with a molecular mass of 66 kDa is phosphorylated by
PKC-a isolated from mitotic cells with a four times higher
e⁄ciency, in the absence of lipid cofactor, as compared to
the kinase obtained from interphasic cells. This activation of
PKC-a at the metaphase is also detectable as auto-phospho-
rylation of the kinase molecule. The loss of lipid requirement,
shown by PKC-a from mitotic cells, is not due to accumula-
tion of free catalytic fragments produced by proteolytic events
during mitosis, as indicated by the presence of similar levels of
the native form of kinase in metaphasic and interphasic cells
and also by the absence of low Mr PKC-a immunoreactive
forms in both conditions. A heat-stable protein factor, which
co-immunoprecipitates with PKC-a in MEL cells at the meta-
phase, has been found to be responsible for the catalytic acti-
vation of this kinase and substituting the classical lipid cofac-
tors. The presence of intracellular complexes between PKC
isoenzymes and PKC activating proteins has been yet identi-
¢ed and proposed as an alternative mechanism to localize
active PKCs in a speci¢c cell site. It has recently been dem-
onstrated that PKC-K binds and is activated by syndecan-4
transmembrane heparan sulfate [33], whereas PKC-LII and
PKC-O bind on di¡erent domains and are activated by F-actin
[34,35]. Another stimulating agent of PKC is the HMG1 pro-
tein, known as a DNA binding molecule [36]. This protein
stimulates both PKC-K and PKC-L activity increasing their
maximal catalytic activity and substituting their requirement
for diacylglycerol [37]. A similar e¡ect on cPKC isoenzymes
has also been described for strati¢n, a member of the 14.3.3
protein family [38]. It has been reported that some PKC
isoenzymes operate as modulators of di¡erent cell functions
following their interaction with speci¢c proteins, such as
phosphatidylinositol-4-kinase and phosphatidylinositol-4-
phosphate-5-kinase, which bind PKC-W at speci¢c membrane
sites [39] and the metalloprotease-disintegrin MDC9 involved
in the regulated shedding through binding to PKC-N [40].
Taken together, our results show that PKC-a is recovered
in an active form when it is associated to the mitotic appara-
tus and a heat stable protein factor is responsible for the
catalytic activation in the absence of lipid cofactors. Experi-
ments aimed to identify this PKC-a stimulating protein are in
progress.
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